JPS5761035B2 - - Google Patents

Info

Publication number
JPS5761035B2
JPS5761035B2 JP49085967A JP8596774A JPS5761035B2 JP S5761035 B2 JPS5761035 B2 JP S5761035B2 JP 49085967 A JP49085967 A JP 49085967A JP 8596774 A JP8596774 A JP 8596774A JP S5761035 B2 JPS5761035 B2 JP S5761035B2
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP49085967A
Other versions
JPS5041859A (ja
Inventor
Mooto Satsuton Burein
Ueinsutotsuku Josefu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline LLC
Original Assignee
SmithKline Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Corp filed Critical SmithKline Corp
Publication of JPS5041859A publication Critical patent/JPS5041859A/ja
Publication of JPS5761035B2 publication Critical patent/JPS5761035B2/ja
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6536—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and sulfur atoms with or without oxygen atoms, as the only ring hetero atoms
    • C07F9/6539—Five-membered rings
    • C07F9/6541—Five-membered rings condensed with carbocyclic rings or carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6503—Five-membered rings
    • C07F9/6506—Five-membered rings having the nitrogen atoms in positions 1 and 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6503—Five-membered rings
    • C07F9/6506—Five-membered rings having the nitrogen atoms in positions 1 and 3
    • C07F9/65068—Five-membered rings having the nitrogen atoms in positions 1 and 3 condensed with carbocyclic rings or carbocyclic ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6536—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and sulfur atoms with or without oxygen atoms, as the only ring hetero atoms
    • C07F9/6539—Five-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP49085967A 1973-08-01 1974-07-26 Expired JPS5761035B2 (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US384666A US3883546A (en) 1973-08-01 1973-08-01 S-heterocyclic derivatives of phosphine or phosphite gold mercaptides

Publications (2)

Publication Number Publication Date
JPS5041859A JPS5041859A (ja) 1975-04-16
JPS5761035B2 true JPS5761035B2 (ja) 1982-12-22

Family

ID=23518252

Family Applications (1)

Application Number Title Priority Date Filing Date
JP49085967A Expired JPS5761035B2 (ja) 1973-08-01 1974-07-26

Country Status (9)

Country Link
US (1) US3883546A (ja)
JP (1) JPS5761035B2 (ja)
BE (1) BE818218A (ja)
CA (1) CA1054609A (ja)
DE (1) DE2437147C2 (ja)
FR (1) FR2240014B1 (ja)
GB (1) GB1422899A (ja)
SE (1) SE7409800L (ja)
ZA (1) ZA744598B (ja)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4165380A (en) * 1977-02-25 1979-08-21 Smithkline Corporation Bis(sulfide)gold(1+) salts
US4172833A (en) * 1978-03-20 1979-10-30 R. T. Vanderbilt Company, Inc. Process for preparation of 2-mercaptotoluimidazole and salts thereof
EP0153307A4 (en) * 1983-08-10 1987-03-12 Richard F Stockel USE OF SELENIUM-CONTAINING COMPOUNDS TO PREVENT THE TOXIC EFFECTS OF GOLD COMPOUNDS USED IN THE TREATMENT OF RHEUMATOID ARTHRITIS, AND A NEW SELENIUM-CONTAINING GOLD COMPOUND AND THE USE THEREOF ASEM.
WO2015181551A1 (en) * 2014-05-28 2015-12-03 Auspherix Limited Gold (i)-phosphine compounds as anti-bacterial agents
KR20170012288A (ko) * 2014-05-28 2017-02-02 오스페릭스 리미티드 항균제로서의 금 (i)-포스핀 화합물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL131206C (ja) * 1965-09-03
US3755329A (en) * 1970-12-22 1973-08-28 Du Pont Nitrogen-heterocyclylgold(i) compounds

Also Published As

Publication number Publication date
US3883546A (en) 1975-05-13
DE2437147C2 (de) 1983-03-03
FR2240014B1 (ja) 1978-07-21
BE818218A (fr) 1975-01-29
DE2437147A1 (de) 1975-02-13
AU7180774A (en) 1976-02-05
SE7409800L (ja) 1975-02-03
CA1054609A (en) 1979-05-15
JPS5041859A (ja) 1975-04-16
ZA744598B (en) 1975-07-30
FR2240014A1 (ja) 1975-03-07
GB1422899A (en) 1976-01-28

Similar Documents

Publication Publication Date Title
AU476761B2 (ja)
AR201235Q (ja)
AR201231Q (ja)
BR7407611D0 (ja)
AR201229Q (ja)
JPS5761035B2 (ja)
AR199451A1 (ja)
AU477823B2 (ja)
AR200256A1 (ja)
AR197627A1 (ja)
AU476873B1 (ja)
AR196382A1 (ja)
AR200885A1 (ja)
AR195948A1 (ja)
AR195311A1 (ja)
AR201432A1 (ja)
AR193950A1 (ja)
AU477824B2 (ja)
AR210729A1 (ja)
AR196212Q (ja)
AR196123Q (ja)
CH562216A5 (ja)
AU479521A (ja)
CH563681A5 (ja)
CH563906A5 (ja)